World Health Organization
In Geneva in November 2017, the World Health Organization presented a report on «Cannabidiol».
This report was written under the responsibility of the World Health Organization (WHO) secretariat, the Department of Essential Medicines and Health Products (Teams of Innovation, Access and Use and Policy, Governance and Knowledge).
University of Salerno
The Department of Medicine and the Department of Pharmacy of the University of Salerno (Italy) has issued some scientific publications on the «Therapeutic Applications of CBD».
(Pharmacology & Therapeutics 2017).
University of Modena and Reggio Emilia, University of Siena
«iNfiammation, cancer and oxidative stress»
The Department of Life Sciences (University of Modena and Reggio Emilia) and the Department of Physical, Earth and Environmental Sciences (University of Siena) on the «Cannabis Sativa and Cannabinoid non-psychoactive. Chemistry and role against Inflammation, Cancer and Oxidative Stress» .
(Bio Med Research International 2018).
University of Santa Catarina, Brazil
«CBD for Post-Traumatic Stress»
The Department of Pharmacology and Neuro-Psycho-Pharmacology of the University of Santa Catarina (Brazil) on «Cannabidiolas a valid therapeutic alternative for post-traumatic stressdisorder».
(Frontiers in Neuroscience 2018)..
University of Skopje, Macedonia
«CBD for pain of serious illnesses»
The Department of Pharmacology of the University of Skopje (Macedonia) on the «Use of Cannabinoids for pain in patients with serious illnesses».
(Journal of Pain Research 2018).
General Research Institute, General Hospital and University of Toronto
«chemical profile of cannabis extracts»
The General Research Institute, General Hospital and The University of Toronto (Canada) have exhibited the «Chemical profile of Medical Cannabis Extracts».
(American Chemical Society 2017).
University of Nottingham, Royal Derby Hospital Centre and Oxford Biomedical Research Centre
«Cannabidiol and blood pressure»
The Medical Sciences Division of the University of Nottingham, the Royal Derby Hospital Centre and the NIHR Oxford Biomedical Research Centre (UK) on «Cannabidiol and bloodpressure».
(Clinical Medicine 2017).
University of Mannheim, Germany
«CBD as a potential new Antipsychotic»
The Department of Psychiatry and Psychotherapy of the University of Mannheim (Germany) on «Cannabidiol as a potential new Antipsychotic».
(Frontiers in Pharmacology 2016).